(19)
(11) EP 4 236 918 A1

(12)

(43) Date of publication:
06.09.2023 Bulletin 2023/36

(21) Application number: 20955432.8

(22) Date of filing: 22.09.2020
(51) International Patent Classification (IPC): 
A61K 9/16(2006.01)
A61K 9/52(2006.01)
A61K 31/565(2006.01)
 A61K 9/48(2006.01)
A61K 31/4164(2006.01)
A61P 31/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4164; A61P 31/04; A61K 31/567; A61K 9/5078; A61K 9/167
 
C-Sets:
  1. A61K 31/567, A61K 2300/00;
  2. A61K 31/4164, A61K 2300/00;
(86) International application number:
PCT/US2020/052032
(87) International publication number:
WO 2022/066146 (31.03.2022 Gazette 2022/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Lupin Inc.
Baltimore, Maryland 21202 (US)

(72) Inventors:
  • PENTIKIS, Helen, S.
    Baltimore, MD 21224 (US)
  • PALLING, David
    Philadelphia, PA 19123 (US)
  • BRAUN, Carol, J
    . (US)
  • HOLL, Richard
    Rolla, MO 65401 (US)
  • KAUFMAN, Gregory
    Short Hills, NJ 07078 (US)

(74) Representative: Hobson, David James et al
Mathys & Squire The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING TRICHOMONIASIS AND USES THEREOF